GlassScriptPhysician profile
Jason R Cornelius
NPI 1982610739
$12,165.30
in general payments reported to CMS, 2019-2025
7 companies · $755 in 2025
The $755 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $3,516 · 2021: $4,210 · 2022: $1,825 · 2023: $138 · 2024: $1,447 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,925 · Food and Beverage: $265 · Honoraria: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,925.00 |
| Food and Beverage | $265.22 |
| Honoraria | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $12,009.16 | 2019-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $49.28 | 2021-2024 | |
| Philips North America LLC | $48.03 | 2019 | |
| Ge Healthcare | $16.13 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.21 | 2020 | |
| Lilly USA, LLC | $13.95 | 2024 | Emgality, Reyvow |
| Resmed Corp | $13.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Cornelius listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.